Oura is partnering with medical device maker Dexcom to integrate data from glucose biosensors with the Oura Ring, which ...

DexCom, Inc. DXCM reported third ... The broader S&P 500 index has moved up 21.6% in the same period. Image Source: Zacks Investment Research Sensor and other revenues (96% of total revenues ...

DexCom invests $75M in Finnish health tech firm ŌURA, forming a strategic partnership to integrate glucose data with vital signs and biometrics.

Revenue declined 1.6% year-over-year from $713.6 million in ... Every study in these AID systems has been done with the DexCom sensor. So there aren't any head-to-head studies.

DexCom, Inc. DXCM is scheduled to release third ... Currently, the Zacks Consensus Estimate for revenues is pegged at $991.6 million, indicating growth of 1.7% from the year-ago quarter’s ...

While there is some optimism around Dexcom’s efforts to rebuild the Durable Medical Equipment (DME) channel and the filing of the 15-day G-Series sensor with the FDA, the softer US performance ...

Sensor and other revenues (96% of total revenues ... Total assets amounted to $6.35 billion, down sequentially from $6.79 billion. DexCom reiterated its outlook for 2024 revenues.